TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.94
+0.09 (0.12%)
At close: May 22, 2026, 4:00 PM EDT
68.46
-0.48 (-0.69%)
After-hours: May 22, 2026, 7:57 PM EDT

TransMedics Group Revenue

TransMedics Group had revenue of $173.93M in the quarter ending March 31, 2026, with 21.18% growth. This brings the company's revenue in the last twelve months to $635.89M, up 30.24% year-over-year. In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth.

Revenue (ttm)
$635.89M
Revenue Growth
+30.24%
P/S Ratio
3.75
Revenue / Employee
$708,118
Employees
898
Market Cap
2.38B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025605.49M163.95M37.13%
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 31, 201813.02M5.33M69.38%
Dec 30, 20177.69M-5.33M-40.96%
Dec 31, 201613.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Enovis2.28B
Integer Holdings1.86B
LivaNova1.43B
Haemonetics1.33B
Neogen870.56M
iRhythm Holdings787.85M
NovoCure674.41M
UFP Technologies608.85M
Revenue Rankings